Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 17
1972 3
1973 6
1974 7
1975 10
1976 19
1977 9
1978 5
1979 11
1980 9
1981 4
1982 7
1983 5
1984 6
1985 6
1986 4
1987 3
1988 2
1989 5
1990 9
1991 4
1992 1
1993 4
1994 3
1995 6
1996 5
1997 3
1998 9
1999 7
2000 4
2001 6
2002 4
2003 4
2004 3
2005 9
2006 8
2007 4
2008 9
2009 6
2010 6
2011 7
2012 1
2013 3
2014 3
2015 7
2016 4
2017 6
2018 4
2019 5
2020 3
2021 2
2022 5
2023 2
2024 2
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

301 results

Results by year

Filters applied: . Clear all
Page 1
Fluocinonide.
[No authors listed] [No authors listed] 2021 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999769 Free Books & Documents. Review.
Fluocinonide has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids may cause systemic effects in the mother, it is unlikely that short-term application of topical corticosteroids would pose a risk to the breastfed in …
Fluocinonide has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids may cause …
Oral lichen planus: comparative efficacy and treatment costs-a systematic review.
Sandhu S, Klein BA, Al-Hadlaq M, Chirravur P, Bajonaid A, Xu Y, Intini R, Hussein M, Vacharotayangul P, Sroussi H, Treister N, Sonis S. Sandhu S, et al. BMC Oral Health. 2022 May 6;22(1):161. doi: 10.1186/s12903-022-02168-4. BMC Oral Health. 2022. PMID: 35524296 Free PMC article.
The majority of evidence suggested efficacy of topical steroids (dexamethasone, clobetasol, fluocinonide, triamcinolone), topical calcineurin inhibitors (tacrolimus, pimecrolimus, cyclosporine), topical retinoids, intra-lesional triamcinolone, aloe-vera gel, photodynamic t …
The majority of evidence suggested efficacy of topical steroids (dexamethasone, clobetasol, fluocinonide, triamcinolone), topical cal …
Painful Oral Lesions.
Hargitai IA. Hargitai IA. Dent Clin North Am. 2018 Oct;62(4):597-609. doi: 10.1016/j.cden.2018.06.002. Epub 2018 Aug 14. Dent Clin North Am. 2018. PMID: 30189985 Review.
The mainstay of OVD management is topical or systemic corticosteroids to include topical triamcinolone, fluocinonide, and clobetasol, whereas systemic medications used in practice can include dexamethasone, prednisone, and prednisolone. ...
The mainstay of OVD management is topical or systemic corticosteroids to include topical triamcinolone, fluocinonide, and clobetasol, …
Tazarotene.
Foster RH, Brogden RN, Benfield P. Foster RH, et al. Drugs. 1998 May;55(5):705-11; discussion 712. doi: 10.2165/00003495-199855050-00008. Drugs. 1998. PMID: 9585866 Review.
In one study in patients with psoriasis, tazarotene had similar efficacy to fluocinonide in reducing plaque elevation, but not erythema. In another study, tazarotene was reported to be less effective than fluocinonide. ...
In one study in patients with psoriasis, tazarotene had similar efficacy to fluocinonide in reducing plaque elevation, but not erythe …
Congenital alopecia areata.
Lenane P, Pope E, Krafchik B. Lenane P, et al. J Am Acad Dermatol. 2005 Feb;52(2 Suppl 1):8-11. doi: 10.1016/j.jaad.2004.06.024. J Am Acad Dermatol. 2005. PMID: 15692503 Review.
Treatments used included minoxidil 2% and a range of topical steroids including hydrocortisone 1%, betamethasone valerate 0.05%, fluocinonide 0.05%, and clobetasol propionate 0.05%. The best regrowth observed resulted from the use of clobetasol propionate 0.05%, giving ful …
Treatments used included minoxidil 2% and a range of topical steroids including hydrocortisone 1%, betamethasone valerate 0.05%, fluocino …
Impact of Topical Fluocinonide on Oral Lichen Planus Evolution: Randomized Controlled Clinical Trial.
Polizzi A, Tartaglia GM, Santonocito S, Alibrandi A, Verzì AE, Isola G. Polizzi A, et al. Oral Dis. 2025 Feb;31(2):510-521. doi: 10.1111/odi.15156. Epub 2024 Oct 14. Oral Dis. 2025. PMID: 39402896 Free PMC article. Clinical Trial.
OBJECTIVE: To examine the impact of fluocinonide 0.05% gel formulation for the topical treatment of oral lichen planus (OLP). ...Anxiety, depression, and stress were significant predictors of OLP outcomes and positively impacted the treatment with fluocinonide at 6 …
OBJECTIVE: To examine the impact of fluocinonide 0.05% gel formulation for the topical treatment of oral lichen planus (OLP). ...Anxi …
Drugs for atopic dermatitis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Jun 15;62(1600):89-96. Med Lett Drugs Ther. 2020. PMID: 32555122 No abstract available.
Fluocinonide.
[No authors listed] [No authors listed] Nursing. 1972 Nov;2(11):37-8. Nursing. 1972. PMID: 4496324 No abstract available.
Fluocinonide.
[No authors listed] [No authors listed] Nurs Times. 2005 Jan 4-10;101(1):47. Nurs Times. 2005. PMID: 15666433 No abstract available.
[Scabies].
Fernández T, de Fernández CC. Fernández T, et al. Rev Ecuat Hig Med Trop. 1977 Jan-Mar;30(1):47-56. Rev Ecuat Hig Med Trop. 1977. PMID: 607327 Spanish. No abstract available.
301 results